Company Press Releases

eCobalt Provides Feasibility Study Update and Commences Pre-Construction Activities on the Idaho Cobalt Project

2017-08-09 / @newswire

VANCOUVER, Aug. 9, 2017 /CNW/ - eCobalt Solutions Inc. (TSX: ECS; OTCQB: ECSIF) (the "Company" or "eCobalt") is providing an update on its Feasibility Study ("FS") and recently initiated pre-construction activities on its 100% owned Idaho Cobalt Project ("ICP") in anticipation of final FS receipt...Read More

eCobalt Provides Feasibility Study Update and Commences Pre-Construction Activities on the Idaho Cobalt Project

2017-08-09 / @newswire

VANCOUVER, Aug. 9, 2017 /PRNewswire/ - eCobalt Solutions Inc. (TSX: ECS; OTCQB: ECSIF) (the "Company" or "eCobalt") is providing an update on its Feasibility Study ("FS") and recently initiated pre-construction activities on its 100% owned Idaho Cobalt Project ("ICP") in anticipation of final FS r...Read More

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW and CCD) Announce Monthly Distributions for August 2017

2017-07-31 / @newswire

NAPERVILLE, Ill., July 31, 2017 /PRNewswire/ -- Calamos Investments (R)* announced today the declaration of monthly distributions on each common share of its six closed-end funds. Fund Distribution(Level Rate) Payabledate Recorddate Ex-dividenddate CHI (inception 06/26/2002)Calamo...Read More

Capstone Mining Second Quarter 2017 Financial Results

2017-07-31 / @newswire

(All amounts in US$ unless otherwise specified) VANCOUVER, July 31, 2017 /CNW/ - Capstone Mining Corp. ("Capstone" or the "Company") (TSX: CS) today announced its financial results for the three and six months ended June 30, 2017. Cash flow from operating activities for the quarter was $4.1 mil...Read More

HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema

2017-07-25 / @newswire

KING OF PRUSSIA, Pa., July 25, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human]) is now available in the United States. The U.S. Food and Drug Administration (FDA) approved HAEGARDA on June 22, 2017...Read More

CSR Targets Asian Market for Cobalt

2017-07-25 / @newswire

COQUITLAM, BC, July 25, 2017 /CNW/ - Castle Silver Resources Inc. (TSX.V: CSR, OTC: TAKRF, FRANKFURT: 4T9B) (the "Company" or "CSR"), is pleased to provide a corporate update as the company advances its battery sector strategy through its proprietary Re-2OX process after recent meetings in Asia....Read More

CobalTech Clarifies Technical Disclosure

2017-07-24 / @marketwired

TORONTO, ON--(Marketwired - July 24, 2017) - COBALTECH MINING INC. (TSX VENTURE: CSK) (FRANKFURT: 9BN1) (WKN: A2DG59) (OTC PINK: BNCIF) (the "Company" or "CobalTech"), reports that as a result of a review by the British Columbia Securities Commission ("BCSC") we are issuing the following news...Read More

Castle Silver Resources Underground Sample Returns High-Grade Cobalt and Gold, Drilling Continues, Private Placement Closes - Video Available on Investmentpitch.com

2017-07-24 / @newsfile

Vancouver, British Columbia--(Newsfile Corp. - July 24, 2017) -Castle Silver Resources (TSXV: CSR) (OTC: TAKRF) (FSE: 4T9B), has issued a shareholder update. An 82-kilogram sample of vein material was recently taken from the first level of its flagship past producing high-grade Castle Silver-Cobalt...Read More

Alabama Graphite Receives ADEM Permit for Final Infill Trenching Program for the Coosa Graphite Project Feasibility Study

2017-07-24 / @marketwired

The Energy Graphite(TM) Company Sourced and Manufactured in the United States of America TORONTO, ONTARIO--(Marketwired - July 24, 2017) - Alabama Graphite Corp. ("AGC" or the "Company") (TSX VENTURE:CSPG)(OTCQB:CSPGF)(FRANKFURT:1AG) is pleased to announce receipt of the necess...Read More

CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human])

2017-07-21 / @newswire

KING OF PRUSSIA, Pa., July 21, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted the Company seven years of orphan-drug exclusivity for HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human]), the first and...Read More

FDA Accepts CSL Behring's Supplemental Biologics License Application for Hizentra (R) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Indication

2017-07-19 / @newswire

KING OF PRUSSIA, Pa., July 19, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (BLA) for Hizentra (R) [Immune globulin subcutaneous...Read More

CSR Underground Composite Sample Returns High-Grade Cobalt and Gold, Phase 1 Drilling Expanded

2017-07-19 / @newswire

COQUITLAM, BC, July 19, 2017 /CNW/ - Castle Silver Resources Inc. (TSX.V: CSR, OTC: TAKRF, FRANKFURT: 4T9B) (the "Company" or "CSR"), is pleased to provide an exploration and corporate update as the Company ramps up drilling at its 100%-owned Castle Property in the prolific northern Ontario Cobal...Read More

Corsa Coal Provides Interim Update and Announces Second Quarter 2017 Reporting Date

2017-07-18 / @newswire

CANONSBURG, PA, July 18, 2017 /CNW/ - Corsa Coal Corp. (TSXV: CSO) ("Corsa" or the "Company") announces that it will issue its second quarter earnings release after the market close on Wednesday, August 16th.An updated investor presentation has been added to www.corsacoal.com. Update on Second Q...Read More

CSR Closes Non-Brokered Private Placement

2017-07-14 / @newswire

COQUITLAM, BC, July 14, 2017 /CNW/ - Castle Silver Resources Inc. (TSX.V: CSR, OTC: TAKRF, FRANKFURT: 4T9B) (the "Company" or "CSR"), is pleased to announce that it has closed a non-brokered private placement with strategic investors, raising gross proceeds of $882,500.The Company issued 4,412,500...Read More

New Data Demonstrate Prophylactic Treatment with IDELVION (R) Reduces Bleed Frequency and Has Potential to Positively Impact Patients with Haemophilia B

2017-07-12 / @newswire

BERLIN, July 12, 2017 /PRNewswire/ -- CSL Behring today presented data finding that prophylaxis treatment with IDELVION (R) provides consistently high factor IX levels, resulting in low bleeding rates in both adult and paediatric patients with haemophilia B. Results were presented at the Internat...Read More

CSR Drilling Targets Cobalt-Rich System at Castle Mine

2017-07-11 / @newswire

COQUITLAM, BC, July 11, 2017 /CNW/ - Castle Silver Resources Inc. (TSX.V: CSR, OTC: TAKRF, FRANKFURT: 4T9B) (the "Company" or "CSR") is pleased to announce that an aggressive 2017 diamond drilling program has commenced at the Castle Property near Gowganda, Ontario, mined historically only for its...Read More

Alabama Graphite Corp. Awards Coosa Graphite Project Feasibility Study to AGP Mining; Contracts Thompson Engineering for Environmental and Mine Permitting

2017-07-12 / @marketwired

The Energy Graphite(TM) Company Sourced and Manufactured in the United States of America TORONTO, ONTARIO--(Marketwired - July 12, 2017) - Alabama Graphite Corp. ("AGC" or the "Company") (TSX VENTURE:CSPG) (OTCQB:CSPGF) (FRANKFURT:1AG) is pleased to announce that independent en...Read More

Capstone Mining 2017 Second Quarter Production Results

2017-07-12 / @newswire

VANCOUVER, July 12, 2017 /CNW/ - Capstone Mining Corp. ("Capstone") (TSX: CS) today announced production results for the three and six months ended June 30, 2017. Combined production totalled 24,000 and 44,900 tonnes of copper in the second quarter and year-to-date periods, respectively, with add...Read More

CSL Behring Awards Researchers to Advance Immunoglobulin Therapy in Treating Neurological Disorders

2017-07-11 / @newswire

SITGES, Spain, July 11, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced at the Peripheral Nerve Society's annual meeting the winners of its annual Interlaken Leadership Awards. There are two 2017 recipients of this global awards program which provides monetary...Read More

CSR Drilling Targets Cobalt-Rich System at Castle Mine

2017-07-11 / @newswire

COQUITLAM, BC, July 11, 2017 /CNW/ - Castle Silver Resources Inc. (TSX.V: CSR, OTC: TAKRF, FRANKFURT: 4T9B) (the "Company" or "CSR") is pleased to announce that an aggressive 2017 diamond drilling program has commenced at the Castle Property near Gowganda, Ontario, mined historically only for its...Read More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok